316 related articles for article (PubMed ID: 16924115)
1. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.
Sitar T; Popowicz GM; Siwanowicz I; Huber R; Holak TA
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13028-33. PubMed ID: 16924115
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the regulation of insulin-like growth factors by IGF binding proteins.
Siwanowicz I; Popowicz GM; Wisniewska M; Huber R; Kuenkele KP; Lang K; Engh RA; Holak TA
Structure; 2005 Jan; 13(1):155-67. PubMed ID: 15642270
[TBL] [Abstract][Full Text] [Related]
3. Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding.
Kuang Z; Yao S; McNeil KA; Thompson JA; Bach LA; Forbes BE; Wallace JC; Norton RS
Biochemistry; 2007 Dec; 46(48):13720-32. PubMed ID: 17985932
[TBL] [Abstract][Full Text] [Related]
4. The N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFs.
Chandrashekaran IR; Yao S; Wang CC; Bansal PS; Alewood PF; Forbes BE; Wallace JC; Bach LA; Norton RS
Biochemistry; 2007 Mar; 46(11):3065-74. PubMed ID: 17305365
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-2: contributions of the C-terminal domain to insulin-like growth factor-1 binding.
Kibbey MM; Jameson MJ; Eaton EM; Rosenzweig SA
Mol Pharmacol; 2006 Mar; 69(3):833-45. PubMed ID: 16306230
[TBL] [Abstract][Full Text] [Related]
6. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
[TBL] [Abstract][Full Text] [Related]
7. Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3.
Dubaquié Y; Lowman HB
Biochemistry; 1999 May; 38(20):6386-96. PubMed ID: 10350456
[TBL] [Abstract][Full Text] [Related]
8. Partial IGF affinity of circulating N- and C-terminal fragments of human insulin-like growth factor binding protein-4 (IGFBP-4) and the disulfide bonding pattern of the C-terminal IGFBP-4 domain.
Ständker L; Braulke T; Mark S; Mostafavi H; Meyer M; Höning S; Giménez-Gallego G; Forssmann WG
Biochemistry; 2000 May; 39(17):5082-8. PubMed ID: 10819974
[TBL] [Abstract][Full Text] [Related]
9. [The structural organization of binding determinants in insulin-like growth factor-I (IGF-I) molecule].
Kolychev AP
Zh Evol Biokhim Fiziol; 2010; 46(1):74-94. PubMed ID: 20297673
[TBL] [Abstract][Full Text] [Related]
10. Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.
Headey SJ; Leeding KS; Norton RS; Bach LA
J Mol Endocrinol; 2004 Oct; 33(2):377-86. PubMed ID: 15525596
[TBL] [Abstract][Full Text] [Related]
11. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor.
Jansson M; Uhlen M; Nilsson B
Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004
[TBL] [Abstract][Full Text] [Related]
12. Perlustrin, a Haliotis laevigata (abalone) nacre protein, is homologous to the insulin-like growth factor binding protein N-terminal module of vertebrates.
Weiss IM; Göhring W; Fritz M; Mann K
Biochem Biophys Res Commun; 2001 Jul; 285(2):244-9. PubMed ID: 11444832
[TBL] [Abstract][Full Text] [Related]
13. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.
Claussen M; Kübler B; Wendland M; Neifer K; Schmidt B; Zapf J; Braulke T
Endocrinology; 1997 Sep; 138(9):3797-803. PubMed ID: 9275067
[TBL] [Abstract][Full Text] [Related]
14. Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I.
Li YM; Arkins S; McCusker RH; Donovan SM; Liu Q; Jayaraman S; Dantzer R; Kelley KW
J Immunol; 1996 Jan; 156(1):64-72. PubMed ID: 8598495
[TBL] [Abstract][Full Text] [Related]
15. Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions.
Lowman HB; Chen YM; Skelton NJ; Mortensen DL; Tomlinson EE; Sadick MD; Robinson IC; Clark RG
Biochemistry; 1998 Jun; 37(25):8870-8. PubMed ID: 9636028
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
Robinson SA; Rosenzweig SA
Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
[TBL] [Abstract][Full Text] [Related]
17. Interaction of insulin-like growth factor (IGF)-I and -II with IGF binding protein-2: mapping the binding surfaces by nuclear magnetic resonance.
Carrick FE; Hinds MG; McNeil KA; Wallace JC; Forbes BE; Norton RS
J Mol Endocrinol; 2005 Jun; 34(3):685-98. PubMed ID: 15956340
[TBL] [Abstract][Full Text] [Related]
18. IGF binding proteins and their functions.
Clemmons DR
Mol Reprod Dev; 1993 Aug; 35(4):368-74; discussion 374-5. PubMed ID: 7691098
[TBL] [Abstract][Full Text] [Related]
19. The insulin-like growth factor-binding protein (IGFBP) superfamily.
Hwa V; Oh Y; Rosenfeld RG
Endocr Rev; 1999 Dec; 20(6):761-87. PubMed ID: 10605625
[TBL] [Abstract][Full Text] [Related]
20. Discovery and characterization of IGFBP-mediated endocytosis in the human retinal pigment epithelial cell line ARPE-19.
Ainscough SL; Feigl B; Malda J; Harkin DG
Exp Eye Res; 2009 Nov; 89(5):629-37. PubMed ID: 19540231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]